Abstract
Introduction

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease primarily affecting middle-aged women; it is an autoimmune liver disease (1). The cause of PBC is unknown, but is thought to be the result of immunoregulation leading to progressive destruction of interlobular bile ducts
and selective disturbance of bile secretion (1, 2) . The trigger event is typically unknown, but PBC can be induced by drugs, environment and/or infections agents (1, 3, 4 
F i g u r e 1 . S e v e r e h y a l i n i z a t i o n a n d f i b r o t i c c h a n g e s i n b i l i a r y e p i t h e l i a l d u c t s s u r r o u n d e d b y i n f l a mma t o r y c e l l s . L y m p h o c y t e s a l s o i n f i l t r a t e d i n t o t h e p o r t a l v e i n ( He ma t o x y l i n a n d E o s i n s t a i n i n g ) .
was started on ursodeoxycholic acid (UDCA) at 600 mg three times daily, and standard liver function tests, including AST, ALT, ALP and IgM returned to normal after several months. In contrast, AMA returned to normal (less than 20-fold) when one year passed. Liver biopsy was not done.
Discussion
PBC is a chronic cholestatic, autoimmune liver disease, the cause of which is unknown (1, 2). Middle-aged women typically suffer from this disease, and immunological and genetic factors (familial association with HLA-DR8 locus) are known to play a role in onset (1). PBC exhibits elevated serum IgM and serum hyper autoantibodies, while liver biopsy specimens reveal reactions with antigens on the surface of biliary epithelial cells (1-3).
Some drugs induce liver injury via an autoimmune mechanism (4) . Metabolites derived from drugs may cause an autoimmune response or lead to direct toxic effects in hepatocytes. In addition, chemotherapeutic drugs, Chinese herbs (5) and the use of interferon therapy (6) have been reported to induce autoimmune hepatitis.
Drugs (phenothiazine, methyltestosterone, tolbutamide, interferon) (7, 8) 
